Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.59 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.59 |
| ▸ | SELL | P14151 | 3/20 | 0.44 |
| ▸ | SELP | P16109 | 3/20 | 0.44 |
| ▸ | SELE | P16581 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | LDHA | P00338 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | GJB2 | P29033 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | TLR4 | O00206 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sucrose SCHEMBL16859920 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE | |
| Sucrose SCHEMBL949885 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE | |
| Sucrose SCHEMBL5030245 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE | |
| Sucrose SCHEMBL285512 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE | |
| Sucrose SCHEMBL18141748 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE | |
| Sucrose SCHEMBL21121139 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE | |
| Sucrose SCHEMBL1067854 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE | |
| Sucrose SCHEMBL3947585 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE | |
| Sucrose SCHEMBL1878330 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE | |
| Sucrose SCHEMBL1874820 | 1.00 | CDK1 (0.59) | CDK1CCNB1SELLSELPSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3651801-B1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | NAPP PHARMACEUTICAL GROUP LTD (GB) | 2026-05-20 | — | — | EP | claimed |
| EP-4304563-B1 | PULLULAN CAPSULES | CAPSUGEL BELGIUM NV (BE) | 2024-12-04 | — | — | EP | claimed |
| EP-3658110-B1 | ORAL CARE COMPOSITIONS | FIRMENICH & CIE (CH) | 2023-04-05 | — | — | EP | claimed |
| EP-3962455-B1 | NEW PHARMACEUTICAL COMPOSITION FOR DRUG DELIVERY | OREXO AB (SE) | 2022-08-31 | — | — | EP | claimed |
| EP-4093368-B1 | SKIN CARE COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12508218-B2 | Coating compositions | COTY INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-3103523-B1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | PROCTER & GAMBLE (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250152487-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-05-15 | — | — | US | disclosed |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250127707-A1 | FRAGRANCE FORMULATION | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250032371-A1 | ETHANOL-FREE FRAGRANCE CHASSIS | COTY INC. | 2025-01-30 | — | — | US | disclosed |
| US-12178896-B2 | Fragrance compositions and uses thereof | COTY INC. (US) | 2024-12-31 | — | — | US | disclosed |
| WO-2012172425-A1 | TRANSLUCENT AND SYRUPY COSMETIC COMPOSITION | CHANEL PARFUMS BEAUTE (FR) | 2012-12-20 | — | — | WO | disclosed |
| EP-2428200-A2 | Novel compositions | Malvern Cosmeceutics Limited (GB) | 2012-03-14 | — | — | EP | disclosed |
| US-20100062067-A1 | COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT | MALVERN COSMECEUTICS LIMITED (GB) | 2010-03-11 | — | — | US | disclosed |
| US-20090240044-A1 | PROCESS FOR THE REDUCTION OF ENDOTOXINS IN A PLASMID PREPARATION USING A CARBOHYDRATE NON-IONIC DETERGENT WITH SILICA CHROMATOGRAPHY | SIGMA-ALDRICH COMPANY (US) | 2009-09-24 | — | — | US | disclosed |
| EP-2099410-A2 | COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT | Malvern Cosmeceutics Limited (GB) | 2009-09-16 | — | — | EP | disclosed |
| US-7531308-B2 | Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography | SIGMA-ALDRICH CO. (US) | 2009-05-12 | — | — | US | disclosed |
| WO-2008065451-A2 | COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT | MALVERN COSMECEUTICS LIMITED (GB) | 2008-06-05 | — | — | WO | disclosed |
| US-20050245733-A1 | Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography | SIGMA-ALDRICH CO. | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12178896-B2 | Fragrance compositions and uses thereof | FHIT, ALG3, FEM1B | CDK1 4776/4885CCNB1 4327/4885SELL 3872/4885 |
| US-20250032371-A1 | ETHANOL-FREE FRAGRANCE CHASSIS | OR51E2, FDFT1, ELANE | CDK1 4409/4885CCNB1 4011/4885SELL 1375/4885 |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | TRPA1, TRPV1, NAA40 | CDK1 3873/4885CCNB1 4448/4885SELL 4372/4885 |
| US-20250127707-A1 | FRAGRANCE FORMULATION | PUF60, POLM, ADH5 | CDK1 3597/4885CCNB1 2697/4885SELL 4425/4885 |
| US-20090240044-A1 | PROCESS FOR THE REDUCTION OF ENDOTOXINS IN A PLASMID PREPARATION USING A CARBOHYDRATE NON-IONIC DETERGENT WITH SILICA CHROMATOGRAPHY | SI, DDOST, LITAF | CDK1 4646/4885CCNB1 3661/4885SELL 364/4885 |
| US-12508218-B2 | Coating compositions | TAS2R40, TAS2R20, TAS2R10 | CDK1 3208/4885CCNB1 4129/4885SELL 648/4885 |
| US-20050245733-A1 | Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography | SI, DDOST, LITAF | CDK1 4646/4885CCNB1 3661/4885SELL 364/4885 |
| US-20100062067-A1 | COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT | CLTB, APOB, ABCB4 | CDK1 4854/4885CCNB1 2235/4885SELL 1972/4885 |
| US-20250152487-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | FHIT, ALG3, FEM1B | CDK1 4776/4885CCNB1 4327/4885SELL 3872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.